ProShares Ultra Nasdaq Biotechnology Rating $50.52 -0.03 (-0.06%) As of 01/17/2025 03:58 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends ProShares Ultra Nasdaq Biotechnology Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BIB Aggregate RatingModerate Buy 2.68Holdings in BIB have an aggregate rating of Moderate Buy based on 720 analyst ratings issued in the past year covering 47 companies (58.3% of the portfolio).BIB Aggregate Price Target$50.52High Prediction$50.52Average Prediction$50.52Low Prediction$50.52Holdings in BIB have an aggregate price target of $50.52 and a range of $50.52 to $50.52 covering 47 companies (58.3% of the portfolio).BIB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ProShares Ultra Nasdaq Biotechnology Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 47 BIB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.55%GILDGilead Sciences$91.84+0.2%4.3805 of 5 stars2.70$97.96 6.7%27Insider TradeShort Interest ↑News Coverage5.98%AMGNAmgen$272.11+1.0%4.8863 of 5 stars2.44$314.91 15.7%27News CoveragePositive NewsGap Up5.75%REGNRegeneron Pharmaceuticals$681.58-1.7%4.6617 of 5 stars2.65$1,015.38 49.0%23Analyst ForecastNews Coverage5.64%VRTXVertex Pharmaceuticals$422.00+1.2%4.1779 of 5 stars2.52$490.38 16.2%312.88%AZNAstraZeneca$66.60-0.5%3.7993 of 5 stars3.00$89.75 34.8%10Short Interest ↑2.32%ALNYAlnylam Pharmaceuticals$246.27-1.2%4.3743 of 5 stars2.72$298.61 21.3%25Analyst Revision1.62%BIIBBiogen$140.55-0.5%4.712 of 5 stars2.43$230.00 63.6%28Short Interest ↑1.59%ILMNIllumina$136.67-0.5%4.6444 of 5 stars2.70$165.63 21.2%20Short Interest ↓News Coverage1.51%ARGXargenx$640.52-2.9%2.2908 of 5 stars2.86$658.39 2.8%22Analyst ForecastAnalyst RevisionNews Coverage1.21%UTHRUnited Therapeutics$358.93-2.0%4.9214 of 5 stars2.73$378.36 5.4%15Analyst UpgradeInsider TradeShort Interest ↓Positive News1.16%MRNAModerna$34.06+0.9%4.7326 of 5 stars2.13$75.58 121.9%23Analyst ForecastOptions VolumeAnalyst RevisionNews Coverage1.11%VTRSViatris$11.30-0.4%2.3498 of 5 stars2.00$13.67 20.9%3Short Interest ↑1.08%SNYSanofi$50.742.902 of 5 stars3.00$57.50 13.3%31.06%SMMTSummit Therapeutics$19.03+4.6%2.8416 of 5 stars2.86$33.57 76.4%71.05%NBIXNeurocrine Biosciences$143.26+0.9%4.8553 of 5 stars2.83$164.81 15.0%23Insider Trade1.00%INCYIncyte$71.93-0.7%4.7395 of 5 stars2.35$76.29 6.1%20Analyst ForecastShort Interest ↓0.95%BMRNBioMarin Pharmaceutical$61.53+0.5%4.9993 of 5 stars2.74$94.20 53.1%23Options VolumeNews Coverage0.94%INSMInsmed$72.51-0.3%2.7812 of 5 stars3.00$83.67 15.4%16Insider TradeShort Interest ↑News Coverage0.88%SRPTSarepta Therapeutics$118.00+0.8%4.9256 of 5 stars2.91$178.71 51.5%22Analyst ForecastAnalyst RevisionNews Coverage0.84%RPRXRoyalty Pharma$30.75-0.6%4.8126 of 5 stars3.00$41.67 35.5%7Dividend IncreaseOptions Volume0.83%BNTXBioNTech$111.93-0.7%3.0103 of 5 stars2.88$142.72 27.5%17Short Interest ↑0.79%PCVXVaxcyte$85.30-2.9%1.9841 of 5 stars3.00$145.71 70.8%8Insider TradeAnalyst RevisionNews Coverage0.79%MEDPMedpace$337.35+0.2%4.5487 of 5 stars2.45$380.56 12.8%110.72%EXELExelixis$36.20-1.0%4.5356 of 5 stars2.53$35.50 -1.9%19Analyst ForecastShort Interest ↑Analyst RevisionNews Coverage0.68%ITCIIntra-Cellular Therapies$126.200.0%3.7969 of 5 stars2.67$100.31 -20.5%15Analyst Forecast0.65%ROIVRoivant Sciences$11.15+2.4%3.6806 of 5 stars2.88$17.93 60.8%8Insider TradeOptions VolumePositive News0.63%ASNDAscendis Pharma A/S$128.13-2.7%3.6129 of 5 stars2.93$192.07 49.9%14Short Interest ↓0.61%BGNEBeiGene2.4025 of 5 stars2.75$253.69 0.0%8Positive News0.57%RVMDRevolution Medicines$40.29+1.0%4.4701 of 5 stars3.08$66.25 64.4%12News Coverage0.56%JAZZJazz Pharmaceuticals$121.18-1.2%4.98 of 5 stars2.87$177.00 46.1%15Short Interest ↓News Coverage0.51%MDGLMadrigal Pharmaceuticals$293.64+7.6%4.5507 of 5 stars2.69$351.67 19.8%13Analyst ForecastInsider TradeAnalyst RevisionNews Coverage0.45%HALOHalozyme Therapeutics$54.80-1.0%4.5963 of 5 stars2.60$60.89 11.1%10Short Interest ↑Analyst Revision0.43%IONSIonis Pharmaceuticals$31.43-2.6%4.1301 of 5 stars2.68$60.65 93.0%19Analyst ForecastInsider TradeNews Coverage0.43%CYTKCytokinetics$45.74-2.7%4.313 of 5 stars2.80$83.64 82.9%15Analyst Forecast0.43%BPMCBlueprint Medicines$110.05+5.9%1.6641 of 5 stars2.65$122.72 11.5%20Analyst ForecastInsider TradeShort Interest ↑Analyst Revision0.40%BBIOBridgeBio Pharma$33.79-0.9%4.0863 of 5 stars2.86$48.08 42.3%14Short Interest ↑0.40%NUVLNuvalent$75.84-0.2%1.793 of 5 stars2.86$112.36 48.2%14Analyst ForecastInsider TradeNews Coverage0.40%TEMTempus AI$35.15+1.2%3.0345 of 5 stars2.75$56.36 60.4%12Analyst ForecastInsider TradeShort Interest ↑Gap Down0.37%CRNXCrinetics Pharmaceuticals$37.35+2.4%3.72 of 5 stars3.00$74.40 99.2%10Short Interest ↑0.36%ALKSAlkermes$29.47-0.9%4.4033 of 5 stars2.64$36.00 22.2%11Short Interest ↓0.34%KRYSKrystal Biotech$148.39+2.5%4.8312 of 5 stars3.00$206.67 39.3%8Short Interest ↓Positive News0.32%ACLXArcellx$66.48-0.8%3.1778 of 5 stars3.13$105.93 59.3%15Short Interest ↑0.32%AXSMAxsome Therapeutics$91.93-1.9%4.6334 of 5 stars3.00$130.69 42.2%13Analyst RevisionGap Up0.32%SRRKScholar Rock$43.13-1.8%3.1277 of 5 stars3.14$40.43 -6.3%7Positive News0.31%ADMAADMA Biologics$16.02-3.7%3.9377 of 5 stars3.25$21.25 32.6%4Short Interest ↑Analyst RevisionPositive NewsGap Down0.30%APLSApellis Pharmaceuticals$29.93+0.7%4.3998 of 5 stars2.63$46.65 55.9%19Analyst ForecastInsider TradeShort Interest ↑Gap Up0.30%RAREUltragenyx Pharmaceutical$40.00-2.1%4.599 of 5 stars2.93$92.29 130.7%14Analyst RevisionNews Coverage This page (NASDAQ:BIB) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIB Stock Alerts